HTI – Talk Bio

Actionable Insights Powered by AI

Gilead Sciences Acquires Investigational HIV Vaccine Assets from AELIX Therapeutics

Gilead Sciences, AELIX Therapeutics, HIV vaccine, HTI immunogen, IrsiCaixa, HIVACAT program